Excess Deaths Upon Cessation of Xanthine Oxidase Inhibitor Treatment-Data From the Cardiovascular Safety of Febuxostat and Allopurinol in Patients With Gout and Cardiovascular Morbidities Trial: Comment on the Article by Choi et al

被引:8
作者
Bubb, Michael R. [1 ,2 ]
机构
[1] Malcom Randall Dept Vet Affairs Med Ctr, Gainesville, FL 32608 USA
[2] Univ Florida, Coll Med, Gainesville, FL 32611 USA
关键词
DISCONTINUATION;
D O I
10.1002/art.40914
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:1391 / 1392
页数:2
相关论文
共 5 条
  • [1] Effects of Discontinuation of Urate-Lowering Therapy: A Systematic Review
    Beslon, Virginie
    Moreau, Perrine
    Maruani, Annabel
    Maisonneuve, Hubert
    Giraudeau, Bruno
    Fournier, Jean-Pascal
    [J]. JOURNAL OF GENERAL INTERNAL MEDICINE, 2018, 33 (03) : 358 - 366
  • [2] Implications of the Cardiovascular Safety of Febuxostat and Allopurinol in Patients With Gout and Cardiovascular Morbidities Trial and the Associated Food and Drug Administration Public Safety Alert
    Choi, Hyon
    Neogi, Tuhina
    Stamp, Lisa
    Dalbeth, Nicola
    Terkeltaub, Robert
    [J]. ARTHRITIS & RHEUMATOLOGY, 2018, 70 (11) : 1702 - 1709
  • [3] Drug Discontinuation Effects Are Part of the Pharmacology of a Drug
    Reidenberg, Marcus M.
    [J]. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2011, 339 (02) : 324 - 328
  • [4] Medication adherence among patients with gout: A systematic review and meta-analysis
    Scheepers, Lieke E. J. M.
    van Onna, Marloes
    Stehouwer, Coen D. A.
    Singh, Jasvinder A.
    Arts, Ilja C. W.
    Boonen, Annelies
    [J]. SEMINARS IN ARTHRITIS AND RHEUMATISM, 2018, 47 (05) : 689 - 702
  • [5] Cardiovascular Safety of Febuxostat or Allopurinol in Patients with Gout
    White, William B.
    Saag, Kenneth G.
    Becker, Michael A.
    Borer, Jeffrey S.
    Gorelick, Philip B.
    Whelton, Andrew
    Hunt, Barbara
    Castillo, Majin
    Gunawardhana, Lhanoo
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2018, 378 (13) : 1200 - 1210